Ips Cell-Derived Drug for Parkinson’s May Get OK for Health Insurance

The Health, Labor and Welfare Ministry will consider whether to cover a medicine derived from induced pluripotent stem cells for the treatment of Parkinson’s disease under the public health insurance scheme, it has been learned.

Go to News Site